Procter & Gamble Health Share PriceProcter & Gamble Health

₹5112.9
2.8 (0.05%)
As on 30 September, 2023 | 16:04 BSE: 500126 NSE: PGHLISIN: INE199A01012

Procter & Gamble Health Performance

Day Range

  • Low 5064.65
  • High 5135.7
5112.9

52 Week Range

  • Low 3870.1
  • High 5500
5112.9
  • Open Price5134.65
  • Previous Close5110.1
  • Volume3091

Start SIP in Procter & Gamble Health

Start SIP

Procter & Gamble Health Share Price

  • Over 1 Month 7%
  • Over 3 Month -1.54%
  • Over 6 Month 11.84%
  • Over 1 Year 27.71%

Procter & Gamble Health Key Statistics

P/E Ratio 37
PEG Ratio 1.9
Market Cap Cr 8,487
Price to Book Ratio 11.3
EPS 138.2
Dividend 1.1
Relative Strength Index 55.66
Money Flow Index 63.27
MACD Signal -40.5
Average True Range 135.78

Procter & Gamble Health Investment Rating

  • Master Rating:
  • Procter & Gamble Health has an operating revenue of Rs. 1,229.62 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 26% is great, ROE of 30% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Health Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 301321310298296268
Operating Expenses Qtr Cr 256243200207236199
Operating Profit Qtr Cr 4580110915969
Depreciation Qtr Cr 6610776
Interest Qtr Cr 000000
Tax Qtr Cr 141928231314
Net Profit Qtr Cr 305977644151
IndicatorJun 2023Jun 2022
Total Revenue Annual Cr 1,2481,128
Operating Expenses Annual Cr 906847
Operating Profit Annual in Cr 324268
Depreciation Cr 2727
Interest Annual Cr 10
Tax Annual Cr 8561
Net Profit Annual Cr 229193
IndicatorJun 2023Jun 2022
Cash from Operating Activity Annual Cr 170
Cash from Investing Activity Annual Cr -26
Cash from Financing Annual Activity Cr -289
Net Cash Flow Annual Cr -145
IndicatorJun 2023Jun 2022
Total ShareHolders Funds Annual Cr 751616
Fixed Assets Annual Cr 176152
Total Non Current Assets Annual Cr 305280
Total Current Assets Annual Cr 796614
Total Assets Annual Cr 1,101894
IndicatorJun 2023Jun 2022
Book Value Per Share Annual Rs 452371
ROE Annual % 3131
ROCE Annual % 4039
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2825
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorJun 2023Jun 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorJun 2023Jun 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorJun 2023Jun 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorJun 2023Jun 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5112.9
2.8 (0.05%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹5026.4
  • 50 Day
  • ₹5071.09
  • 100 Day
  • ₹5033.89
  • 200 Day
  • ₹4889.87
  • 20 Day
  • ₹5009.81
  • 50 Day
  • ₹5132.69
  • 100 Day
  • ₹5115.67
  • 200 Day
  • ₹4810.17

Procter & Gamble Health Resistance and Support

PIVOT
₹5104.42
Resistance
First Resistance ₹5144.19
Second Resistance ₹5175.47
Third Resistance ₹5215.24
RSI 55.66
MFI 63.27
MACD Single Line -40.5
MACD -17.59
Support
First Resistance ₹5073.14
Second Resistance ₹5033.37
Third Resistance ₹5002.09

Procter & Gamble Health Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,770 212,590 56.39
Week 11,071 625,057 56.46
1 Month 12,279 750,969 61.16
6 Month 11,470 697,948 60.85

Procter & Gamble Health Result Highlights

Procter & Gamble Health Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1229.62 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2023. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
Market Cap 8,487
Sales 1,230
Shares in Float 0.80
No of funds 134
Yield 1.86
Book Value 11.3
U/D Vol ratio 1.1
LTDebt / Equity
Alpha 0.1
Beta 0.15

Procter & Gamble Health

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 51.82%51.82%51.82%51.82%
Mutual Funds 8.1%7.34%7.28%6.9%
Insurance Companies 4.08%4.87%5.11%5.66%
Foreign Portfolio Investors 7.15%6.72%6.33%6.05%
Financial Institutions/ Banks
Individual Investors 23.64%24.09%24.32%24.46%
Others 5.21%5.16%5.14%5.11%

Procter & Gamble Health Management

Name Designation
Mr. Suresh Talwar Chairman & Ind.Director
Mr. Milind Thatte Managing Director
Mr. Amit Gupta Executive Director & CFO
Mr. Aalok Agrawal Non Executive Director
Dr. Elizabeth Desmond Non Executive Director
Mrs. Rani Jadhav Independent Director
Mr. S Madhavan Independent Director
Mr. Lokesh Chandak Director
Mr. Seema Sambasivan Director

Procter & Gamble Health Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Health Corporate Action

Date Purpose Remarks
2023-11-03 Quarterly Results
2023-08-23 Audited Results & Final Dividend
2023-05-15 Quarterly Results
2023-02-05 Quarterly Results & Interim Dividend
2022-11-11 Quarterly Results (Revised) per share(4160%)Special Dividend
Date Purpose Remarks
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 36540
HDFC Small Cap Fund Growth 22560
Aditya Birla Sun Life MNC Fund Payout Inc Dist cum Cap Wdrl 3462
UTI MNC Fund Regular Plan Growth 2610
Sundaram Small Cap Fund - Regular Plan - Growth Option 2582
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Procter & Gamble Health FAQs

What is Share Price of Procter & Gamble Health ?

Procter & Gamble Health share price is ₹5112 As on 30 September, 2023 | 15:50

What is the Market Cap of Procter & Gamble Health ?

The Market Cap of Procter & Gamble Health is ₹8487.1 Cr As on 30 September, 2023 | 15:50

What is the P/E ratio of Procter & Gamble Health ?

The P/E ratio of Procter & Gamble Health is 37 As on 30 September, 2023 | 15:50

What is the PB ratio of Procter & Gamble Health ?

The PB ratio of Procter & Gamble Health is 11.3 As on 30 September, 2023 | 15:50

Q2FY23